Bipartisan Bill Revives Insulin Cost Cuts

Diabetes advocates hold cautious hope as a bipartisan bill reignites push to slash insulin prices, countering Big Pharma's grip and government red tape that inflates costs for everyday Americans. This rare Washington win cuts through liberal spending sprees to deliver real relief without expanding bloated entitlements. Common sense prevails: lower prices mean more liberty for patients, less dependency on DC handouts. Read more about this...